Physician
Radiation Oncology
Dr. Karen E. Hoffman, MD
|
|
Give Review
Karen Hoffman is an expert in the field of Radiation Oncology. She went to Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine Dr. Karen E. Hoffman has written publications. She has 48 publications published with PubMed. The lastest paper is: 'Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.' Karen E. Hoffman, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Approp...
- Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients.
- In reply to Rusthoven and Kavanagh.
- Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique.
- Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at six months compared to conventionally fractionated whole breas...
- Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status.
- Considerations for Observational Research Using Large Data Sets in Radiation Oncology.
- Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.
- Physician Variation in Management of Low-Risk Prostate Cancer: A Population-Based Cohort Study.
- Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States.
- Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period.
- Refusal of Curative Radiation Therapy and Surgery Among Patients With Cancer.
- Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial.
- The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer.
- The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-contr...
- Quantification of beam complexity in intensity-modulated radiation therapy treatment plans.
- Management of Advanced Primary Urethral Carcinomas.
- Benefit of Adjuvant Brachytherapy Versus External Beam Radiation for Early Breast Cancer: Impact of Patient Stratification on Breast Preservation.
- Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer.
- Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?
- Declining use of brachytherapy for the treatment of prostate cancer.
- Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients.
- Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients.
- Management of prostate cancer in elderly men.
- Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation.
- Outcomes and Predictive Factors for Salvage Therapy After Local-Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy.
- Outcomes in stage I testicular seminoma: A population-based study of 9193 patients.
- Radiation therapy modalities in prostate cancer.
- Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
- PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation The...
- Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.
- Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate c...
- American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns.
- Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?
- Emergence of Integrated Urology-Radiation Oncology Practices in the State of Texas.
- Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?
- Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative Surgery.
- Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy.
- Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy.
- Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.
- The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.
- Local recurrence map to guide target volume delineation after radical prostatectomy.
- Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: Implications for targeting the undissected axilla.
- Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy...
- The implications of ageing and life expectancy in prostate cancer treatment.
- Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
- Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.
Schools
Duke University
Fairfax Inova Hospital
Harvard Radiation Oncology Program
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Georgetown University Hospital -
Duke University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1982689410 | |
| NPPES Provider LastName | HOFFMAN | |
| NPPES Provider FirstName | KAREN | |
| NPPES Provider ZIPCode | 770304000 | |
| NPPES Provider State | TX | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 35.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982689410 |
| Last Name Of The Provider | HOFFMAN |
| First Name Of The Provider | KAREN |
| View All |
Similar Doctors
|
|
Dr. Thomas J. Pugh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam S. Garden, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Beth M. Beadle, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Ritsuko Komaki, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Christopher H. Crane, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. James D. Cox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph S. Kong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bouthaina S. Dabaja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mirna Abboud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Bishop, MD |
|
|
Dr. Jack Phan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cameron H. Swanick, MD
This Doctor is OpenDoctor Recommended.
|